Co-Diagnostics, Inc. Gains 91.29%
Wed, Mar 11, 2020 at 05:30 PM
Co-Diagnostics, Inc. (CODX:NASDAQ) soared at $13.18, a gain of 91.3%. The stock got featured on our News Catalysts scanner on Fri 06 Mar 20 at 04:42 PM in the 'MISCELLANEOUS' category. From Tue 25 Feb 20, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Fri 28 Feb 20 at $21.75 with a volume of 27M+.
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- Ladenburg Thalmann Financial Services Inc (LTSK:NYSEMKT), 142.86%
- BIO-key International, Inc. (BKYI:NASDAQ), 140.82%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 92.68%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 91.29%
- Ladenburg Thalmann Financial Services Inc (LTSH:NYSEMKT), 53.85%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 50%
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 46.84%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 44.79%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 42.07%
- Mallinckrodt plc (MNK:NYSE), 39.27%